Merck (MRK) Shares Outstanding (2009 - 2026)

Merck (MRK) has reported Shares Outstanding (Entity) for 18 consecutive years, with $2.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 1.23% year-over-year to $2.5 billion in Q2 2026; TTM through Jun 2026 was $2.5 billion, a 1.23% decrease from a year earlier, with the FY2025 full-year figure at $2.5 billion, down 2.12% from the prior year.
• Shares Outstanding (Entity) was $2.5 billion for Q2 2026 at Merck, roughly flat from $2.5 billion in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $2.5 billion in Q4 2022 and troughed at $2.5 billion in Q2 2026.
• A 5-year average of $2.5 billion and a median of $2.5 billion in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) rose 0.43% in 2022 and declined 2.12% in 2025, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $2.5 billion in 2022, then declined by 0.23% to $2.5 billion in 2023, then dropped by 0.26% to $2.5 billion in 2024, then dropped by 2.12% to $2.5 billion in 2025, then declined by 0.21% to $2.5 billion in 2026.
• The last three Shares Outstanding (Entity) figures came in at $2.5 billion (Q2 2026), $2.5 billion (Q1 2026), and $2.5 billion (Q4 2025), per Business Quant data.